141 related articles for article (PubMed ID: 24750749)
1. Inclusion complex of astaxanthin with hydroxypropyl-β-cyclodextrin: UV, FTIR, 1H NMR and molecular modeling studies.
Yuan C; Jin Z; Xu X
Carbohydr Polym; 2012 Jun; 89(2):492-6. PubMed ID: 24750749
[TBL] [Abstract][Full Text] [Related]
2. Inclusion complexation of chloropropham with β-cyclodextrin: preparation, characterization and molecular modeling.
Ge X; He J; Qi F; Yang Y; Huang Z; Lu R; Huang L
Spectrochim Acta A Mol Biomol Spectrosc; 2011 Oct; 81(1):397-403. PubMed ID: 21757399
[TBL] [Abstract][Full Text] [Related]
3. Alpinetin/hydroxypropyl-β-cyclodextrin host-guest system: preparation, characterization, inclusion mode, solubilization and stability.
Ma SX; Chen W; Yang XD; Zhang N; Wang SJ; Liu L; Yang LJ
J Pharm Biomed Anal; 2012; 67-68():193-200. PubMed ID: 22633603
[TBL] [Abstract][Full Text] [Related]
4. Storage stability and antioxidant activity of complex of astaxanthin with hydroxypropyl-β-cyclodextrin.
Yuan C; Du L; Jin Z; Xu X
Carbohydr Polym; 2013 Jan; 91(1):385-9. PubMed ID: 23044147
[TBL] [Abstract][Full Text] [Related]
5. Study of inclusion complex between 2,6-dinitrobenzoic acid and β-cyclodextrin by 1H NMR, 2D 1H NMR (ROESY), FT-IR, XRD, SEM and photophysical methods.
Srinivasan K; Stalin T
Spectrochim Acta A Mol Biomol Spectrosc; 2014 Sep; 130():105-15. PubMed ID: 24769381
[TBL] [Abstract][Full Text] [Related]
6. UV-vis and FTIR-ATR spectroscopic techniques to study the inclusion complexes of genistein with beta-cyclodextrins.
Crupi V; Ficarra R; Guardo M; Majolino D; Stancanelli R; Venuti V
J Pharm Biomed Anal; 2007 May; 44(1):110-7. PubMed ID: 17379467
[TBL] [Abstract][Full Text] [Related]
7. Characterization of an inclusion complex of ethyl benzoate with hydroxypropyl-β-cyclodextrin.
Yuan C; Lu Z; Jin Z
Food Chem; 2014; 152():140-5. PubMed ID: 24444918
[TBL] [Abstract][Full Text] [Related]
8. Molecular simulation of hydroxypropyl-beta-cyclodextrin with hydrophobic selective Cox-II chemopreventive agent using host-guest phenomena.
Sinha VR; Nanda A; Chadha R; Goel H
Acta Pol Pharm; 2011; 68(4):585-92. PubMed ID: 21796941
[TBL] [Abstract][Full Text] [Related]
9. UV-vis and FTIR-ATR characterization of 9-fluorenon-2-carboxyester/(2-hydroxypropyl)-beta-cyclodextrin inclusion complex.
Stancanelli R; Ficarra R; Cannavà C; Guardo M; Calabrò ML; Ficarra P; Ottanà R; Maccari R; Crupi V; Majolino D; Venuti V
J Pharm Biomed Anal; 2008 Aug; 47(4-5):704-9. PubMed ID: 18400444
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the inclusion behavior of chlorogenic acid with hydroxypropyl-β-cyclodextrin.
Chao J; Wang H; Zhao W; Zhang M; Zhang L
Int J Biol Macromol; 2012 Jan; 50(1):277-82. PubMed ID: 22115718
[TBL] [Abstract][Full Text] [Related]
11. Inclusion complexes of pyrimethamine in 2-hydroxypropyl-beta-cyclodextrin: characterization, phase solubility and molecular modelling.
de Araújo MV; Vieira EK; Lázaro GS; de Souza Conegero L; Ferreira OP; Almeida LS; Barreto LS; da Costa NB; Gimenez IF
Bioorg Med Chem; 2007 Sep; 15(17):5752-9. PubMed ID: 17583516
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the binding of roxatidine acetate hydrochloride with cyclomaltoheptaose (β-cyclodextrin) using IR and NMR spectroscopy.
Maheshwari A; Sharma M; Sharma D
Carbohydr Res; 2011 Sep; 346(13):1809-13. PubMed ID: 21816394
[TBL] [Abstract][Full Text] [Related]
13. Complexation of morin with three kinds of cyclodextrin. A thermodynamic and reactivity study.
Jullian C; Orosteguis T; Pérez-Cruz F; Sánchez P; Mendizabal F; Olea-Azar C
Spectrochim Acta A Mol Biomol Spectrosc; 2008 Nov; 71(1):269-75. PubMed ID: 18262835
[TBL] [Abstract][Full Text] [Related]
14. Inclusion of Paracetamol into β-cyclodextrin nanocavities in solution and in the solid state.
El-Kemary M; Sobhy S; El-Daly S; Abdel-Shafi A
Spectrochim Acta A Mol Biomol Spectrosc; 2011 Sep; 79(5):1904-8. PubMed ID: 21703916
[TBL] [Abstract][Full Text] [Related]
15. Investigation of water-soluble inclusion complex of hypericin with β-cyclodextrin polymer.
Zhang W; Gong X; Cai Y; Zhang C; Yu X; Fan J; Diao G
Carbohydr Polym; 2013 Jun; 95(1):366-70. PubMed ID: 23618281
[TBL] [Abstract][Full Text] [Related]
16. Physicochemical, in silico and in vivo evaluation of a danazol-beta-cyclodextrin complex.
Jadhav GS; Vavia PR
Int J Pharm; 2008 Mar; 352(1-2):5-16. PubMed ID: 18023545
[TBL] [Abstract][Full Text] [Related]
17. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ
Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924
[TBL] [Abstract][Full Text] [Related]
18. Supramolecular interaction of Moxifloxacin and β-cyclodextrin spectroscopic characterization and analytical application.
Dsugi NF; Elbashir AA
Spectrochim Acta A Mol Biomol Spectrosc; 2015 Feb; 137():804-9. PubMed ID: 25277628
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and spectroscopy studies of the inclusion complex of 3-amino-5-methyl pyrazole with beta-cyclodextrin.
Louiz S; Labiadh H; Abderrahim R
Spectrochim Acta A Mol Biomol Spectrosc; 2015 Jan; 134():276-82. PubMed ID: 25022499
[TBL] [Abstract][Full Text] [Related]
20. Enhanced dissolution, stability and physicochemical characterization of ATRA/2-hydroxypropyl-β-cyclodextrin inclusion complex pellets prepared by fluid-bed coating technique.
Chen Z; Lu Y; Qi J; Wu W
Pharm Dev Technol; 2013 Feb; 18(1):130-6. PubMed ID: 22304703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
